Growth Company Investor - Stock market recommendations on AIM and small cap companies

3 December 2016

Popular Topics within cash

Oxford BioMedica seeks partners 24/08/10

Out-of-favour Oxford BioMedica is seeking partners to develop two gene therapies after interim losses up 177 per cent to £3.6 million.

Tags: Cash, Deals & contracts, Full list

Hardy shrinks first-half loss 19/08/10

India-focused Hardy Oil and Gas is pursuing expansion after cutting interim losses 76 per cent to $1.35 million (£860,000).

Tags: Cash, Full list

Profits leap at Scientific Digital 19/07/10

Scientific Digital Imaging remains acquisitive after lifting annual pre-tax profits more than fourfold to £258,000.

Tags: AIM, Boardroom moves, Cash, Growth Stocks

Zoo Digital wins US backing

New York-headquartered Multi Packaging Solutions (MPS) is to pay £859,456 for 9.1 per cent of AIM-quoted entertainment software and services provider Zoo Digital, with warrants to double that stake as part of a new strategic relationship between the two companies.

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Turnaround at Falkland Islands  23/06/10

Falkland Island Holdings (FIH) has turned £627,000 annual losses into £5.7 million pre-tax profits and awaits imminent oil drilling results.

Tags: AIM, Cash, Dividend, Turnaround

Interim profits soar at Gooch 08/06/10

Optical components and systems manufacturer Gooch & Housego saw pre-tax profits surge from £39,000 to £1.7 million in the half-year to March.

Tags: AIM, Cash, Growth Stocks

Young's cheers with profits push 03/06/10

AIM-quoted pubs operator Young & Co's Brewery has buoyed investors' spirits with positive profits progression in a challenging year to March.

Tags: AIM, Cash, Growth Stocks

Profits slip at Hamworthy 02/06/10

AIM-listed marine fluid-handling systems specialist Hamworthy has announced a dip in profits for the year to March.

Tags: AIM, Cash, Deals & contracts, Dividend

Renovo moots cosmetic deal 20/05/10

Biopharmaceutical specialist Renovo is discussing potential cosmetic uses for its Juvidex wound-healing product after trimming interim losses.

Tags: Cash, Deals & contracts, Full list, Restructuring

Licence fees boost ImmuPharma 19/05/10

Drug discoverer ImmuPharma has lifted annual pre-tax profits 85 per cent to £9.1 million after a £21 million licence payment.

Tags: AIM, Cash, Deals & contracts

Strategic Thought cuts deficit 12/05/10

Risk management software developer Strategic Thought has reduced losses from £2.1 million to £767,000 on buoyant turnover. 

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Losses double at Southern Cross 11/05/10

Southern Cross Healthcare Group is pinning hopes on its 'New Horizons' recovery policy after nearly doubling interim losses to £22.9 million.

Tags: Boardroom moves, Cash, Full list

Corporate Governance & Activist Investing in Europe

Taking place on September 19th in London, explores the current state of the strategy, its effect on the structure and operations of European corporations, and examines best practices and corporate governance initiatives that public company boards can implement to proactively position themselves against an activist campaign. Click here for more information.

Directors' Pay on AIM 2016

The annual Directors’ Pay on AIM report is the most comprehensive review of directors’ remuneration on AIM available. For more information or to order your copy click here.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today


Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

FREE Step-by-Step Guide to Investment Analysis

Read Phil Oakley’s easy-to-read guide to analysing shares. Learn how to become a confident & successful stock-picker. A must-read for novice and experienced investors alike. Click here to read.

What moves small-cap share prices?

A research report into the top-performing 100 companies below the FTSE 350 and on AIM. Click here to download.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info


Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular Topics